N
Neil Pearce
Researcher at University of London
Publications - 795
Citations - 122260
Neil Pearce is an academic researcher from University of London. The author has contributed to research in topics: Population & Asthma. The author has an hindex of 107, co-authored 729 publications receiving 105762 citations. Previous affiliations of Neil Pearce include Harvard University & Victoria University of Wellington.
Papers
More filters
Journal ArticleDOI
Lung cancer and occupation: A new zealand cancer registry‐based case–control study
Marine Corbin,David McLean,Andrea 't Mannetje,Evan Dryson,Chris Walls,Fiona McKenzie,Milena Maule,Soo Cheng,Chris Cunningham,Hans Kromhout,Aaron Blair,Neil Pearce,Neil Pearce +12 more
TL;DR: Certain occupations and industries have increased lung cancer risks in New Zealand, including wood workers, metal workers, meat workers, textile workers and drivers.
Journal ArticleDOI
Psychological Effects of Chronic Exposure to 50 Hz Magnetic Fields in Humans Living Near Extra-High-Voltage Transmission Lines
TL;DR: Higher time-integrated exposure was associated with poorer coding-test performance and more adverse psychiatric symptomatology, found to be independent of participants' beliefs about effects of electromagnetic fields.
Journal ArticleDOI
Differences in citation rates by country of origin for papers published in top-ranked medical journals: do they reflect inequalities in access to publication?
Olof Akre,Francesco Barone-Adesi,Andreas Pettersson,Neil Pearce,Franco Merletti,Lorenzo Richiardi +5 more
TL;DR: Papers from different countries published in the same journal have different citation rates, which may reflect difficulties for researchers from some countries to publish their research in leading medical journals.
Journal ArticleDOI
What proportion of rhinitis symptoms is attributable to atopy
TL;DR: It seems to be of major importance to differentiate between atopic and other forms of rhinitis, as there is variation between studies but little evidence of systematic geographic variation.
Journal Article
The self-administration of inhaled beta agonist drugs during severe asthma.
TL;DR: Asthmatic patients in New Zealand self-administer high doses of inhaled beta 2 agonist drugs during severe exacerbations of asthma, contrasting with the recommended practice in both the USA and Europe.